|
|
Volumn 19, Issue 9, 2009, Pages 1-
|
|
Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer
a
|
|
Author keywords
Gemcitabine; Ovarian cancer; Platinum sensitivity; Recurrent disease; Vinorelbine
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
NAVELBINE;
PLATINUM DERIVATIVE;
VINBLASTINE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
DRUG RESISTANCE;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
MIDDLE AGED;
MORTALITY;
OVARY TUMOR;
PAPILLARY CARCINOMA;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
RECURRENT DISEASE;
SURVIVAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, PAPILLARY;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
MIDDLE AGED;
OVARIAN NEOPLASMS;
PLATINUM COMPOUNDS;
RECURRENCE;
SURVIVAL ANALYSIS;
VINBLASTINE;
|
|
EID: 85026153931
PISSN: 1048891X
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/IGC.0b013e3181a8407e Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
